In This Section

AACR To Host Several Conferences in Boston Beginning This Week

BOSTON – Beginning this week, the American Association for Cancer Research (AACR) will host several scientific conferences in Boston. Registration for these meetings is complimentary for credentialed members of the media.

AACR Special Conference: Pancreatic Cancer

September 27 – 30, 2023

The 9th AACR Special Conference on Pancreatic Cancer will address the latest developments in pancreatic cancer research, spanning basic, translational, and clinical research areas.

View the conference program and follow the meeting on Twitter: #AACRpan23

AACR Special Conference: Ovarian Cancer

October 5 – 7, 2023

This conference will include sessions on epidemiology and prevention, immunology, tumor microenvironment, drug discovery, epigenetics and epitranscriptomics, and rare ovarian tumors, with the goal of further enhancing the scientific understanding of ovarian cancer biology and supporting the development of better therapeutics.

View the conference program and follow the meeting on Twitter: #AACRovc23

2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

October 11 – 15, 2023

Academics, scientists, and pharmaceutical industry representatives from across the globe will come together to discuss key topics at this year’s conference, including liquid biopsy, antibody-drug conjugate development, T cell and NK cell therapies, the emerging role of therapeutic vaccines and mRNA in cancer, and more.

View the conference program and follow the meeting on Twitter: #Targets23

AACR Special Conference on Endometrial Cancer: Transforming Care Through Science

November 16 – 18, 2023

Endometrial cancer remains one of the few malignancies with rapidly rising mortality and incidence rates, posing a major public health concern for women worldwide. This conference will bring basic scientists and clinical researchers together to discuss opportunities for endometrial cancer prevention and better treatment strategies, which are both critical to reversing these concerning trends and maximizing survival for those diagnosed with this disease.

View the conference program and follow the meeting on Twitter: #AACRec23

AACR Special Conference in Cancer Research: Translating Cancer Evolution and Data Science: The Next Frontier

December 3 – 6, 2023

With session topics ranging from understanding the impact of cancer evolution on clinical research to decoding the evolutionary history of human tumors, this conference offers a unique platform for cancer researchers, oncologists, and data scientists to delve into a cross-disciplinary exploration of cancer evolution and its implications for diagnosis, treatment, and drug discovery.

View the conference program and follow the meeting on Twitter: #AACRevol23


These conferences are in-person events and will not be live streamed for virtual participation. Lecture sessions will be made available for on-demand viewing approximately 7-10 days after the meeting has concluded.

To register for in-person attendance or virtual access after the events, journalists must provide:

  • Official press credentials such as a business card, editorial roster or masthead, international press card, or letter of assignment
  • Bylined coverage from a previous AACR meeting. First-time attendees must provide two examples of recent bylined health/medical/science coverage in news outlets that meet the AACR’s criteria
  • Freelance journalists who have a letter of assignment should upload a copy of the letter to the registration form linked below
  • Members of the Association of Health Care Journalists (AHCJ) may register regardless of assignment and should upload proof of membership to the registration form linked below

Please review the full media registration requirements and policies. Journalists can request registration by filling out this form. Contact Cyprien Pearson-Du Toit at [email protected] or 215-446-7154 with registration questions.


For more information, contact a member of the AACR public relations team: